-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on Sensei Biotherapeutics, Maintains $55 Price Target

Benzinga·06/15/2026 17:01:57
Listen to the news
BTIG analyst Jeet Mukherjee reiterates Sensei Biotherapeutics (NASDAQ:SNSE) with a Buy and maintains $55 price target.